lupus and glp 1 glp-1 lupus At Lupus LA's #LatestOnLupus Conference at UCLA, Dr. Daniel Wallace shared emerging insights into the use of GLP-1 receptor agonists At Lupus LA's #LatestOnLupus Conference – GLP-1s reduce mortality in lupus

The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: a pathophysiological update

Cytochrome P450 2C9 (Cyp2C9) Substrates Theoretically, phellodendron might increase serum levels of drugs metabolized by CYP2C9

Vrbikova J, Dvorakova K, Hill M, Starka L

However, the complex nature of psoriasis, coupled with the limitations of current research methodologies, diagnostic techniques, and gaps in knowledge, contributes to the variability in treatment efficacy among patients, recurrence following drug cessation, and therapeutic failures

A.SchubertH

Clinically proven by FSSAI and GMP (good marketing practice)